Oral Minoxidil for Men UK - From £29.99

Oral minoxidil for men UK is gaining attention as an alternative to topical minoxidil foam and spray formulations for treating male pattern hair loss. While topical minoxidil 5% (such as Regaine Extra Strength Foam, from £29.99 at Cured Pharmacy) remains the licensed first-line option, some UK prescribers now consider low-dose oral minoxidil off-label for androgenetic alopecia when topical treatment proves impractical or poorly tolerated. This guide explains what oral minoxidil is, how it compares to topical formulations, and how UK men can access prescription hair loss treatments through Cured Pharmacy's online clinical service.

What Is Oral Minoxidil for Men UK and How Does It Work?

Oral minoxidil for men UK refers to minoxidil tablets taken by mouth, typically at low doses (0.625–5 mg daily), prescribed off-label for androgenetic alopecia[1]. Minoxidil was originally developed as an antihypertensive medication; hair growth was observed as a side effect, leading to the development of topical minoxidil for hair loss[2]. The oral form works systemically by widening blood vessels around hair follicles, prolonging the anagen (growth) phase, and potentially stimulating dormant follicles.

In the UK, oral minoxidil is not licensed for hair loss and is used outside its approved indication at the prescriber's discretion. Topical minoxidil 5% foam (Regaine Extra Strength) remains the MHRA-licensed option for male pattern baldness. Any prescription for oral minoxidil must follow a thorough clinical assessment by a UK-registered prescriber, who will weigh the potential benefits against cardiovascular and other safety considerations[1].

• Oral minoxidil acts systemically, reaching follicles via the bloodstream rather than topical application
• Licensed in the UK for hypertension, not hair loss; use for alopecia is off-label
• Typical off-label doses for hair loss range from 0.625 mg to 5 mg daily
• Requires prescription and ongoing monitoring by a UK healthcare professional

Oral Minoxidil for Men UK vs Topical Minoxidil: Key Differences

The most significant difference between oral minoxidil for men UK and topical minoxidil is the route of administration and regulatory status. Topical minoxidil 5% foam is applied directly to the scalp twice daily and is licensed by the MHRA for androgenetic alopecia. Clinical trials of topical minoxidil 5% showed that approximately 45% of men experienced moderate to dense regrowth at 48 weeks[2]. Oral minoxidil, by contrast, is taken as a tablet and works throughout the body, which may increase efficacy but also raises the risk of systemic side effects such as fluid retention, increased heart rate, and unwanted hair growth on the face or body[1].

For men who find twice-daily foam application inconvenient, or who have not responded adequately to topical treatment, some UK prescribers may consider low-dose oral minoxidil. However, this decision must be individualised: oral minoxidil requires baseline cardiovascular assessment, regular monitoring, and informed consent regarding off-label use. At Cured Pharmacy, our UK clinical team can discuss both topical and, where clinically appropriate, oral minoxidil options during your free online consultation.

Safety and Monitoring Considerations

Because oral minoxidil for men UK is used off-label, prescribers typically start at the lowest effective dose and monitor blood pressure, heart rate, and any signs of fluid retention[1]. Men with pre-existing cardiovascular conditions, significant hypertension, or heart failure may not be suitable candidates. Topical minoxidil, while generally well tolerated, can cause scalp irritation and an initial shedding phase in the first 2–4 weeks of use[2]. Both formulations require long-term commitment: stopping treatment usually results in gradual loss of any hair regained.

How to Access Oral Minoxidil for Men UK Through Cured Pharmacy

Accessing oral minoxidil for men UK begins with a clinical consultation. At Cured Pharmacy, our free online assessment takes under three minutes and is reviewed by a UK-registered prescriber. If oral minoxidil is deemed clinically appropriate and safe for you, a private prescription can be issued and your medication dispatched in discreet packaging with next-day delivery available. Because oral minoxidil is not licensed for hair loss, our prescribers will explain the off-label nature of the treatment, potential side effects, and monitoring requirements before proceeding.

For many men, topical minoxidil 5% foam (Regaine Extra Strength, from £29.99) or the Hair Loss Combo Pack combining finasteride 1mg tablets with minoxidil foam (from £34.99) may be more suitable first-line options. Finasteride 1mg is licensed for male pattern hair loss and works by inhibiting the enzyme that converts testosterone to dihydrotestosterone (DHT), the hormone that shrinks hair follicles[3]. Your prescriber will recommend the most evidence-based approach for your individual case. Use code Hairlossnew for 20% off your first order.

1. Complete the free online consultation form on the Cured Pharmacy website
2. A UK-registered prescriber reviews your medical history and hair loss pattern
3. If suitable, a prescription is issued and your treatment is dispensed by our GPhC-registered pharmacy
4. Receive discreet next-day delivery; follow-up and repeat prescriptions available online

Hair Loss Treatments Available at Cured Pharmacy

Clinical Evidence for Oral Minoxidil for Men UK in Androgenetic Alopecia

Although oral minoxidil for men UK is used off-label, emerging clinical data support its efficacy. A 2021 systematic review found that low-dose oral minoxidil (0.25–5 mg daily) led to significant hair density improvement in men with androgenetic alopecia, with response rates comparable to or exceeding topical minoxidil in some cohorts[1]. One open-label trial reported that 1.25 mg daily oral minoxidil produced measurable increases in hair count and thickness after six months, with the most common side effect being mild hypertrichosis (excess body or facial hair)[4].

It is important to note that these studies are smaller and shorter than the large-scale trials that established topical minoxidil and finasteride as licensed treatments. The MHRA has not granted a marketing authorisation for oral minoxidil in hair loss, so any prescription in the UK is at the clinician's discretion. Men considering oral minoxidil should have realistic expectations: visible improvement typically takes 3–6 months, results vary widely, and treatment must be continued indefinitely to maintain benefit[1][4].

Comparing Oral Minoxidil to Finasteride and Dutasteride

Finasteride 1mg (licensed for male pattern hair loss) and dutasteride 0.5mg (licensed for benign prostatic hyperplasia, used off-label for hair loss) work by different mechanisms than oral minoxidil for men UK. Finasteride inhibits type II 5α-reductase, reducing scalp DHT by approximately 70%, while dutasteride inhibits both type I and II isoenzymes, achieving greater DHT suppression[3][5]. In head-to-head trials, dutasteride 0.5mg showed superior hair count increases compared to finasteride 1mg at 24 weeks[5]. Oral minoxidil, by contrast, does not affect DHT but promotes follicle blood flow and anagen prolongation. Some prescribers combine oral minoxidil with finasteride or dutasteride for synergistic benefit, though this approach requires careful monitoring and informed consent regarding off-label use.

Benefits and Considerations of Oral Minoxidil for Men UK

The primary appeal of oral minoxidil for men UK is convenience: a once-daily tablet eliminates the need for twice-daily topical application, which some men find time-consuming or cosmetically undesirable. Oral administration also ensures consistent systemic delivery, potentially benefiting men with diffuse thinning across the entire scalp. However, systemic exposure means side effects can occur beyond the scalp, including facial or body hair growth, ankle swelling, light-headedness, and palpitations[1][4].

Before considering oral minoxidil, men should trial licensed treatments where appropriate. At Cured Pharmacy, we stock finasteride 1mg tablets (from £12.49 for 28 tablets), Propecia 1mg (from £49.99), and Regaine Extra Strength 5% Foam (from £29.99), all supported by robust clinical trial data and regulatory approval for male pattern hair loss. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), and the wider clinical team ensure every prescription is evidence-based, safe, and tailored to your needs. All treatments require ongoing use; stopping will reverse gains over several months.

• Once-daily oral dosing may improve adherence compared to twice-daily topical application
• Systemic delivery can address diffuse thinning across the entire scalp
• Off-label status requires informed consent and cardiovascular monitoring
• Licensed alternatives (finasteride, topical minoxidil) have stronger regulatory and trial support
• Combination therapy (oral minoxidil plus finasteride) may be considered for advanced cases

Scientific references

1. Randolph, M., & Tosti, A. (2021). Oral minoxidil treatment for hair loss: A review of efficacy and safety. Journal of the American Academy of Dermatology, 84(3), 737–746. https://doi.org/10.1016/j.jaad.2020.06.1009 [accessed 28 October 2026]
2. Olsen, E. A., Dunlap, F. E., Funicella, T., Koperski, J. A., Swinehart, J. M., Tschen, E. H., & Trancik, R. J. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology, 47(3), 377–385. https://doi.org/10.1067/mjd.2002.124088 [accessed 28 October 2026]
3. Kaufman, K. D., Olsen, E. A., Whiting, D., Savin, R., DeVillez, R., Bergfeld, W., ... & Shapiro, J. (1998). Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology, 39(4), 578–589. https://doi.org/10.1016/S0190-9622(98)70007-6 [accessed 28 October 2026]
4. Vañó-Galván, S., Pirmez, R., Hermosa-Gelbard, Á., Moreno-Arrones, O. M., Saceda-Corralo, D., Rodrigues-Barata, A. R., ... & Camacho-Martinez, F. M. (2021). Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. Journal of the American Academy of Dermatology, 84(6), 1644–1651. https://doi.org/10.1016/j.jaad.2021.02.054 [accessed 28 October 2026]
5. Olsen, E. A., Hordinsky, M., Whiting, D., Stough, D., Hobbs, S., Ellis, M. L., ... & Kaufman, K. D. (2006). The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride. Journal of the American Academy of Dermatology, 55(6), 1014–1023. https://doi.org/10.1016/j.jaad.2006.05.007 [accessed 28 October 2026]
6. NHS. (2026). Hair loss. https://www.nhs.uk/conditions/hair-loss/ [accessed 28 October 2026]
7. NHS. (2026). Finasteride: a medicine to treat an enlarged prostate and male pattern baldness. https://www.nhs.uk/medicines/finasteride/ [accessed 28 October 2026]